News

IMB researchers have identified a small molecule that could 'turn off' inflammation and stop it in its tracks.

IMB scientists are using genomics to unravel the secrets behind the forces between algae and coral, which cause coral bleaching.

A bacteria toxin system could be the key to overcoming pesticide resistance in insects and may lead to new cancer treatments.

In an Australian-first, UQ researchers will join forces with the Global Antibiotic Research and Development Partnership (GARDP) to tackle the growing problem of drug-resistant infections.

Associate Professor Kate Schroder has been recognised for her excellence in biochemistry and molecular biology after being awarded the Merck Research Medal by the Australian Society for Biochemistry and Molecular Biology.

Improving outcomes for children and teenagers with brain cancer will be the focus of Australia’s first research centre aimed solely at tackling the cancer in young people.

A UQ team is seeking to understand how antibiotic-resistant UPEC cause UTI and develop new, immune-based treatment strategies to treat these infections.

Voting has opened for this year's Queensland Women in STEM Prize.

The spade flower, an often-overlooked member of Australian flora, hides some interesting secrets, including a rare chemical that may hold the key to turning regular plants into medicinal cures.

A study that delves into the genes of over a million people has identified 124 genetic variants located on 99 separate regions of the genome associated with risky behaviour.

An ancient class of peptides which likely originated near the dawn of cellular life has been discovered by University of Queensland researchers in the venom of centipedes.

An IMB structural biologist and toxinologist studying molecules found in venom has been named a STEM superstar for inspiring women to get involved in science, technology, engineering and mathematics

Six researchers from UQ’s Institute for Molecular Bioscience have earned the distinct honour of being acknowledged as one of the world’s most influential scientific minds.

Inflazome, a UQ spinout developing new drugs to block harmful inflammation, has secured further investment of $63 million.

The key to discovering new antibiotics and other drugs may lie in the inter-kingdom chemical warfare between fungi and bacteria, according to new research from the University of Queensland (UQ).

IMB researchers and Dr Luregn Schlapbach from the Lady Cilento Children's Hospital are fighting sepsis through developing better diagnostics

A promising new therapy to stop Parkinson's disease, the second-most common neurodegenerative disease worldwide, with 10 million sufferers.

A project using molecules from spider venom to develop improved treatments for chronic pain and stroke will be undertaken by Institute for Molecular Bioscience (IMB) Professor Glenn King in partnership with University of Science and Technology of China, after receiving funding from the Queensland Government.

Researchers have used human stem cells and single-cell sequencing to uncover the complex choreography of heart development